Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2002Australasian Journal of Dermatology

Acitretin for chemoprevention of non‐melanoma skin cancers in renal transplant recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRenu GeorgeChristian Medical College, VelloreWWWarren WeightmanQueen Elizabeth HospitalGRGraeme R. RussRoyal Adelaide Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

George et al. (2002) studied this question.

synapsesocial.com/papers/6a99da4f352e687f024d2a3dhttps://doi.org/10.1046/j.1440-0960.2002.00613.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin1999 · 178 citations
  2. 2Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.1995 · 406 citations
  3. 3Acitretin as Cancer Chemoprophylaxis in a Renal Transplant Recipient2009 · 23 citations
  4. 4BENEFICIAL EFFECT OF LOW-DOSE SYSTEMIC RETINOID IN COMBINATION WITH TOPICAL TRETINOIN FOR THE TREATMENT AND PROPHYLAXIS OF PREMALIGNANT AND MALIGNANT SKIN LESIONS IN RENAL TRANSPLANT RECIPIENTS1995 · 89 citations
  5. 5Treatment of Cutaneous Neoplasia with Etretinate in Renal Transplant Recipients1988 · 72 citations